Overactive bladder and female sexual dysfunction: evaluation by the fsfi and psychosocial effects on quality of life
Overactive bladder and female sexual dysfunction: evaluation by the fsfi and psychosocial effects on quality of life
DOI:
https://doi.org/10.51473/rcmos.v1i1.2026.2001Keywords:
Overactive Bladder Syndrome; Female Sexual Dysfunction; Quality of Life; Female Sexual Function Index.Abstract
This study aimed to investigate the impact of Overactive Bladder Syndrome (OAB) on female sexuality through a literature review. OAB is a clinical condition defined by the presence of urinary urgency, often accompanied by increased frequency and nocturia, with or without urgency urinary incontinence, excluding urinary tract infection or other obvious pathology. It is a highly prevalent chronic condition, affecting between 12.8% and 31.3% of adult women, with an estimated prevalence of 16.6% in the European population and 16.9% in the United States. Female sexual health is an essential component of quality of life, encompassing somatic, emotional, intellectual, and social aspects, with Female Sexual Dysfunction (FSD) affecting approximately 43% of women in the United States, low desire being the most frequent complaint. Several studies have shown that women with OAB have significantly impaired sexual function compared to healthy controls, with markedly lower scores on the Female Sexual Function Index (FSFI) across all domains (desire, arousal, lubrication, orgasm, satisfaction, and pain). Factors such as fear of leakage and unpredictability of urgency contribute to anxiety and loss of self-confidence, leading to low sexual frequency. OAB treatment, including pharmacotherapy, pelvic floor muscle training, and minimally invasive procedures, generally improves sexual function without significant adverse effects. Thus, OAB constitfactorsn independent risk factor for FSD, and proactive evaluation of patients’ sexual health should be part of clinical management to optimize quality of life.
Downloads
References
ATLIHAN, U.; ÖZTÜRK, B.; YAZICI TEKELİ, E.; UYSAL, D. Evaluation of overactive-bladder syndrome’s impact on female sexual function. Pelviperineology, v. 44, n. 1, p. 17–23, 2025.
CAMERON, ANNE P. et al. The AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. The Journal of Urology, 2024.
FONTAINE, C.; PAPWORTH, E.; PASCOE, J.; HASHIM, H. Update on the management of overactive bladder. Therapeutic Advances in Urology, v. 13, 2021.
GAMMIE, ANDREW et al. Laser therapy for urinary incontinence and overactive bladder: a systematic review. Neurourology and Urodynamics, v. 38, n. 4, p. 1236–1245, 2019.
ISHAK, W. W.; TOBIA, G. DSM-5 changes in diagnostic criteria of sexual dysfunctions. Reproductive System & Sexual Disorders, v. 2, p. 122, 2013.
KOCH, MARIANNE et al. Characteristics of female overactive bladder syndrome: results from a large retrospective cohort spanning 15 years. Maturitas, v. 202, p. 108736, 2025.
LEVY, G.; LOWENSTEIN, L. Overactive bladder syndrome treatments and their effect on female sexual function: a review. Sexual Medicine, v. 8, n. 1, p. 1–7, 2020.
LIM-WATSON, M. Z. et al. A systematic literature review of health-related quality of life measures for women with hypoactive sexual desire disorder and female sexual interest/arousal disorder. Sexual Medicine Reviews, v. 10, n. 1, p. 23–41, 2022.
LIN, X. D. et al. Effects of overactive bladder syndrome on female sexual function. Medicine, v. 100, n. 20, p. e25761, 2021.
MOTA, P. et al. Impact of overactive bladder on female sexual function. International Brazilian Journal of Urology, v. 42, n. 6, 2016.
NAUMANN, G. et al. Sexual disorders in women with overactive bladder and urinary stress incontinence compared to controls: a prospective study. Geburtshilfe und Frauenheilkunde, v. 81, n. 9, p. 1039–1046, 2021.
RIBEIRO, JÉSSICA; SCHETTERT DO VALLE, PATRÍCIA ALEXANDRA DOS SANTOS. Disfunção sexual feminina: percepção e impacto na qualidade de vida. Revista Brasileira de Sexualidade Humana, v. 27, n. 2, 2016.
SALVATORE, STEFANO et al. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Climacteric, v. 18, n. 5, p. 757–763, 2015.
SHOURESHI, POONE S.; EILBER, KARYN S. The intersection of female sexual function and overactive bladder. Current Bladder Dysfunction Reports, v. 18, p. 224–229, 2023.
SONDKA-MIGDALSKA, J.; BLASZCZYNSKI, P.; JABLONOWSKI, Z. Sexual dysfunction in patients with overactive bladder syndrome treated with botulinum toxin. Journal of Clinical Medicine, v. 13, n. 19, p. 5869, 2024.
SÖNMEZ, TUĞBA GÜLER et al. The prevalence of incontinence and its impact on quality of life. Medicine, v. 103, n. 52, p. e41108, 2024.
STAMOS, DIMITRIOS et al. Female sexual function and pelvic floor muscle training: a narrative review. Cureus, v. 17, n. 6, e85751, 2025.
TSAI, TE-FU; YEH, CHUNG-HSIN; HWANG, THOMAS I. S. Female sexual dysfunction: physiology, epidemiology, classification, evaluation and treatment. Taipei: Shin-Kong Wu Ho-Su Memorial Hospital, 2009.
ZHANG, BO et al. Association between overactive bladder and female sexual frequency: a cross-sectional analysis of the National Health and Nutrition Examination Survey data. BMC Women’s Health, v. 25, art. 84, 2025.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2026 Isabela Ribeiro Mascarenhas Ferro, Odílio Mendes Frazão (Autor)

This work is licensed under a Creative Commons Attribution 4.0 International License.


